A Democratic congressman is suggesting that public outrage over the increase in price for the EpiPen could help Congress pass legislation allowing Medicare to directly negotiate drug prices with companies.
A Democratic congressman is suggesting that public outrage over the increase in price for the EpiPen could help Congress pass legislation allowing Medicare to directly negotiate drug prices with companies.